Dimitri Sidiropoulos, PhD
I was raised in Crete, an island ~300 km away from Athens, and Europe's southernmost region. At the age of 16 I moved to Minnesota. I pursued my undergraduate studies at the UMN Twin Cities where I double majored in biochemistry and genetics. I conducted my undergraduate research in cross-species FMT and metagenomics advised by Dr. Dan Knights. Upon graduation I joined General Probiotics, an NSF & USDA SBIR-funded startup biotechnology company, as an R&D scientist where we developed genetically engineered probiotics designed to tackle foodborne pathogens.
In June 2023 I earned my PhD from the Cellular and Molecular Medicine Program at the Johns Hopkins University School of Medicine. I pursued my thesis research as a NIH F31 predoctoral fellow at the Sidney Kimmel Comprehensive Cancer Center, co-mentored by Dr. Elizabeth Jaffee, Dr. Elana Fertig and Dr. Won Jin Ho. My dissertation, titled "Cancer Immunomics: Deciphering The Cellular and Molecular Landscapes of Immunotherapies," adapted single-cell and spatial molecular technologies to infer mechanisms of immunotherapy response and resistance in immunosuppressive tumors.
Now, I am a faculty scientist at the Convergence Institute developing computational immuno-pathology methods to track lymphocyte trafficking in immunotherapy clinical trials.
I also provide consulting services for -omics technologies, computational biology & bioinformatics solutions.
Feel free to reach out with any questions.
Copyright © 2024 dsidiropoulos.com - All Rights Reserved.